Stockwinners Market Radar for December 31, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EST Toughbuilt Industries Inc trading halted, news pending

17:22 EST LumiraDx unable to pay outstanding loan, forced to liquidate the company - In a filing, LumiraDx disclosed that the waiver period in the loan agreement has expired as of December 29. As a result of the steps taken to appoint the administrators to LumiraDx Group Limited and LumiraDx International Ltd, events of default under the loan agreement have occurred and the principal amount outstanding under the loan agreement of $361.8M, together with all accrued interest and all other amounts payable under the loan agreement, is now immediately due and payable. LumiraDx Investment Limited is unable to pay the outstanding amount. The collateral agent has also issued a demand against the company, as guarantor, for payment of the outstanding amount. As the Company does not have funds to pay the outstanding amount, it is anticipated that the collateral agent will in due course present a petition for the winding up of the company with a view to having a liquidator appointed over it. The company expects that there will be no assets available for distribution to its shareholders or the unsecured creditors of the LumiraDx group. No demand has been made or enforcement action taken against any other LumiraDx group companies.

17:04 EST Pintec Technology appoints Xin Yang as CFO - Pintec Technology announced the appointment of Xin Yang as CFO of the company. Zexiong Huang has resigned from his position as the acting CFO of the company and will continue to serve as the CEO and a member of the board of directors of the company.

16:54 EST SomaLogic announces Glass Lewis, ISS recommendation for Standard BioTools merger - SomaLogic (SLGC) announced that Glass Lewis has recommended that SomaLogic stockholders vote for the pending merger with Standard BioTools (LAB) at the company's special meeting of stockholders to be held on January 4. Together with the recommendation previously made by Institutional Shareholder Services, or ISS, on December 22 both of the independent proxy advisory firms have recommended that SomaLogic stockholders vote for the pending transaction.

16:45 EST LumiraDx Ltd trading resumes

16:43 EST GRIID, Adit EdTech Acquisition Corp. complete business combination - GRIID Infrastructure, an American bitcoin mining company that leverages a low-cost, low-carbon energy mix to manage and operate vertically integrated bitcoin mining facilities, announced that it completed its business combination with Adit EdTech Acquisition Corp. (ADEX), a publicly traded special purpose acquisition company. Adit EdTech stockholders approved the business combination at a special meeting held on Nov. 30. Following the business combination, the surviving company was renamed GRIID Infrastructure Inc. Beginning on Tuesday, Jan. 2, 2024, GRIID's common stock is expected to trade on Cboe Canada, the new business name of the NEO Exchange, under the ticker symbol "GRDI," and GRIID is seeking to list its common stock and warrants on a U.S. exchange.

16:10 EST LumiraDx Ltd trading halted, news pending

16:07 EST Adit EdTech Acquisition Cor trading halted, news pending

13:21 EST JFrog CEO Shlomi sells $1.68M worth of shares - JFrog CEO Ben Haim Shlomi disclosed the sale of 48,099 shares at an average price of $35.02 for total proceeds of $1.68M via a 10b5-1 plan. Shlomi still owns over 5M shares of JFrog.

13:04 EST Baker Hughes reports U.S rig count up 2 from last week to 662 - Baker Hughes reported the U.S. rig count is up two from last week to 622 with oil rigs up 2 to 500, gas rigs unchanged at 120 and miscellaneous rigs unchanged at two. The U.S. rig count is down 157 rigs from last year's count of 779 with oil rigs down 121, gas rigs down 36 and miscellaneous unchanged at two. The U.S. offshore rig Count is up one to 20, up five year-over-year.

12:20 EST Salem Media sinks after announcing Nasdaq delisting - Salem Media Group announced today that it has given formal notice to the Nasdaq of its intention to voluntarily delist its class A common stock from the Nasdaq. The company currently anticipates that it will file with the Securities and Exchange Commission a notification of removal of listing on or about January 8, 2024, with the delisting taking effect no earlier than ten days thereafter. As a result, the company expects that the last trading day of its common stock on the Nasdaq will be on or about January 18, 2024. Salem Media anticipates "significant financial savings as a result of this decision. In addition, delisting and deregistration provide several benefits to the Company and its stockholders including lower operating costs and reduced management time commitment for compliance and reporting activities," the company said in a statement. Shares of Salem are down 29% to 39c following the news.

12:00 EST TAL Education rises 7.9% - TAL Education is up 7.9%, or 93c to $12.73.

12:00 EST Wheels Up falls -12.5% - Wheels Up is down -12.5%, or -50c to $3.52.

12:00 EST Copel falls -19.7% - Copel is down -19.7%, or -$2.06 to $8.43.

11:45 EST Crixus Bh3 Acquisition Co trading resumes

11:41 EST Flyexclusive Inc trading halted, volatility trading pause

11:12 EST Focus Impact BH3 Acquisition enters LOI with XCF Global Capital - Focus Impact BH3 Acquisition has entered into a letter of intent with XCF Global Capital, a New York-based producer of sustainable fuels. XCF controls multiple plants in North America that will produce renewable diesel, sustainable aviation fuel, and other biofuels. The transaction, which values XCF at $1.75B, is subject to the completion of due diligence, negotiation of and entry into definitive documentation and will be subject to customary closing conditions. There can be no assurances that a transaction will be executed or consummated.

10:45 EST Adit EdTech Acquisition Cor trading halted, volatility trading pause

10:29 EST Jin Medical International Ltd trading halted, volatility trading pause

10:00 EST TAL Education rises 5.1% - TAL Education is up 5.1%, or 60c to $12.40.

10:00 EST Wheels Up falls -5.2% - Wheels Up is down -5.2%, or -21c to $3.81.

10:00 EST Copel falls -17.0% - Copel is down -17.0%, or -$1.78 to $8.71.

09:47 EST Altice USA rises 3.5% - Altice USA is up 3.5%, or 12c to $3.37.

09:47 EST MSCI Brazil Index rises 5708.3% - MSCI Brazil Index is up 5708.3%, or $34.25 to $34.85.

09:47 EST Natural Grocers falls -4.1% - Natural Grocers is down -4.1%, or -66c to $15.52.

09:43 EST Angion Biomedica Corp trading resumes

09:38 EST Cingulate Inc trading resumes

09:34 EST Greenpro Capital's Green-X approves listing of Tai Shan Digital STO - Greenpro Capital announced the company's Digital Asset Exchange, Green-X has approved the listing of Tai Shan Digital. This development marks a significant milestone in the digitization and tokenization of refined Chinese ceramics, sourced from antiquarian collectors, as well as prestigious auction houses. The STO token will be listed under the symbol "TS1" in Green-X.

09:33 EST Angion Biomedica Corp trading halted, volatility trading pause

09:32 EST Knightscope announces expansion contract for six ASRs - Knightscope announces a new expansion contract for 6 Autonomous Security Robots including 2 of its 5th Generation K5s and 4 K1 Hemispheres, bringing the total number of robots under contract for this client to 14.

09:27 EST Focus Impact BH3 Acquisition Co trading halted, news pending

09:07 EST SomaLogic sent letter to stockholders on transaction with Standard BioTools - SomaLogic (SLGC) sent the following open letter to stockholders reiterating the Board's belief that the proposed transaction between SomaLogic and Standard BioTools is in the best interest of all stockholders. "We firmly believe that the value-maximizing transaction with Standard BioTools is the best path forward for SomaLogic and all of its stockholders. You have an essential decision to make regarding the value of your investment... The Standard BioTools (LAB) Merger is Clearly the Best Path Forward . This merger delivers compelling value and potential for SomaLogic stockholders, positioning the Company for long-term success as a leading, well-capitalized and strongly managed provider of differentiated multi-omics tools. While we see tremendous future potential in the proteomics market, it is important to recognize that the path to realizing this potential as a standalone company involves significant execution risk and operational challenges. SomaLogic's co-development partnership with Illumina (ILMN) alone will not guarantee the Company's success. With industry consolidation more broadly, and Illumina focused on its own set of priorities, it is paramount that SomaLogic strengthen its position in the market - and this transaction is the best way to accomplish this... Following the merger, the combined company will benefit from: Dramatically increased scale and diversification; A robust portfolio of life science tools that power industry-leading throughput and data quality; A stronger financial profile and enhanced operating leverage, with over $500 million of cash and only $68 million of debt; $80 million in anticipated run-rate cost synergies achieved by 2026; and A combined Board and leadership team that brings together complementary teams with proven experience.... The transaction is the result of a thorough, independent and deliberative Board process that was focused at all times on identifying strategic options that could maximize value for all SomaLogic stockholders. During this process, the SomaLogic Board engaged with 16 parties to solicit potential interest in a transaction, but no other party expressed any actionable indication of interest and only one, other than Standard BioTools, entered into an NDA... The SomaLogic Board Is Independent and Acting in the Best Interests of ALL SomaLogic Stockholders. Madryn and its group's criticisms of the transaction are without merit and reflect their own self-interest. Contrary to their claims: SomaLogic conducted thorough due diligence on Standard BioTools between June and October, with the assistance of outside legal, financial and strategic consultants... The Board and management changes announced in March 2023 were made with the specific goal of helping SomaLogic realize its tremendous potential... The bottom line is that the strategic rationale of the combination is strong, and the SomaLogic Board of Directors firmly believes this transaction represents the best path forward for SomaLogic and all its stockholders. Leading Independent Proxy Advisory Firm Institutional Shareholder Services Agrees that Stockholders Should Vote "FOR" the Merger"

08:48 EST Altamira Therapeutics regains compliance with Nasdaq minimum bid price rule - Altamira Therapeutics received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market on December 28, 2023, indicating that the Company has regained compliance with the minimum bid price requirement. As a result, the listing matter has been closed. On June 26, 2023, the Company was notified by Nasdaq of its failure to maintain a minimum closing bid price of at least $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a)(2) and was given 180 days, or until December 26, 2023, to regain compliance. Effective December 13, 2023, the Company effected a reverse stock split of its common shares at a ratio of 1-for-20, resulting in a total of 1,477,785 outstanding common shares. The Notice noted that the Company evidenced a closing bid price of its common shares at or greater than $1.00 per share for at least 10 consecutive business days from December 13 through December 27, 2023. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2).

08:32 EST Mobivity reports participation of 30M consumers in Connected Rewards program - Mobivity Holdings achieved a corporate milestone with over 30M consumers participating in its Connected Rewards products. In the last year, two of the largest fuel brands, several top 10 convenience stores, and more than 20 major restaurant chains have all relied upon Mobivity's Connected Rewards technology to connect their brand offers to the 200M U.S. consumers who download and play mobile games monthly. Each participating brand has increased customer and loyalty member acquisition and store transactions without impacting marketing budgets.

08:22 EST Electra Battery Materials appoints David Allen CFO - Electra Battery Materials announced that David Allen has been appointed as CFO of the company. Electra continues to make strong progress on its financing strategy to complete the construction of North America's only battery grade cobalt refinery. Management anticipates receiving funding from previous government commitments very early in 2024, while it advances a larger multi-stakeholder funding solution to complete construction of its hydrometallurgical refinery north of Toronto. The company estimates that the current replacement cost of the refinery complex is $200M and that approximately $60M will be required to complete construction. All long-lead, custom-fabricated equipment is on site, and the facility was operational throughout 2023 as a plant scale demonstration plant, processing battery black mass. Electra has an existing supply agreement with LG Energy Solution which will see LG Energy Solution buy up to 80% of production from Electra's Ontario refinery during the first five years of operation. Demand for the remaining production exceeds Electra's supply capabilities. Approximately 80% of cobalt used in EVs is currently refined in China. Inclusion of this material in U.S. electric vehicles will make them ineligible for $7,500 of vehicle credits under the Inflation Reduction Act.

08:08 EST Bullfrog AI: Objectives 'laser-focused' on securing business, driving revenue - BullFrog AI Holdings issued a letter to shareholders from its CEO Vin Singh, which read in part, "Firstly, I am deeply grateful for your support and belief in our vision to revolutionize drug development. Your faith has been the cornerstone of our success. Looking back at 2023, it is evident that it has been an extraordinary year for BullFrog AI. It has been a year marked by immense progress, innovation, and value-adding events that have completely transformed our company and positioned us for success in 2024 and beyond. Undeniably, this year has been the year of Artificial Intelligence, and we have wholeheartedly embraced the attention and interest surrounding this remarkable technology. Amidst the frenzy and hype surrounding AI, our team has remained steadfast in our focus, diligently executing our plan with unwavering determination. As we reflect on our achievements, it becomes clear that we are steadily marching towards making our vision of revolutionizing drug development a tangible reality...As we turn the page to 2024, the horizon is filled with promise and opportunity. Our objectives are laser-focused on securing business and driving revenue through external discovery and development contracts and partnerships stemming from our internal programs. Our lean team, low overhead expenses, and current market cap create what we believe is a compelling scenario for investors, providing the potential for substantial upside in this rapidly evolving market landscape. Given our float of 2.8 million shares and the high-value transactions in our sector, we believe the future looks incredibly bright for BullFrog AI, our partners, and most importantly, you - our valued shareholders."

08:06 EST Delaware Court rules in favor of AIM ImmunoTech against activist nominations - AIM ImmunoTech announced the Delaware Court of Chancery ruled that the nomination notice submitted by a member of a group of individuals who are seeking to nominate three candidates for election to AIM's four-person board of directors was properly rejected for being invalid under the company's bylaws. This ruling follows a trial held at the end of October in connection with the Activist Group's lawsuit against the company. As a reminder, the AIM Board said it had unanimously determined that the Activist Group's nomination notice was invalid because it omitted key information and included misleading information, ignoring what the company's bylaws require to be disclosed. In light of the court's ruling, the company will disregard the Activist Group's director nominations, and no proxies or votes in favor of their three nominees will be recognized or tabulated at the 2023 annual meeting of stockholders. In reaching its decision, the Court noted the following: "... the Board acted reasonably and equitably in rejecting the [nomination notice submitted by Ted D. Kellner]. It did not breach its fiduciary duties in enforcing valid advance notice bylaws. The plaintiff's group-not the Board-are 'the ones engaging in manipulative conduct.'" "Ultimately, the nondisclosure of certain [arrangements, agreements or understandings] is fatal to Kellner's nomination effort. After the [Jonathan] Jorgl litigation, Kellner, [Robert] Chioini, [Todd] Deutsch and their counsel should have been closely attuned to the importance of completely disclosing all relevant arrangements and understandings. Still, they flouted the Company's advance notice requirements. Because of the timing of Kellner's submission-the night before the submission deadline-there was no possibility of correcting any deficiencies." "The concealment of arrangements and understandings that go to the heart of a nomination effort risks undermining the essential disclosure function of advance notice bylaws. Directors and stockholders would justifiably want to know whether a nomination is part of a broader scheme. Such information was withheld from or obfuscated in the Kellner Notice." Thomas Equels, executive vice chairman of the board, CEO and president, stated: "For the second year in a row, a group of interconnected individuals with seemingly nefarious intentions has tried to take over the AIM Board without paying other shareholders an appropriate premium for that control. We are pleased that the Court has validated the Board's determination that the Activist Group omitted and misrepresented critical information related to its members' backgrounds and intentions for AIM. We believe this will protect the best interests of shareholders as we position the Company to capitalize on important upcoming clinical milestones. We look forward to continuing to build on our significant momentum in delivering life-saving treatments for unmet patient needs as well as creating shareholder value." The company will reconvene its 2023 annual meeting as planned at 11:00 a.m. Eastern Time, and will then adjourn proceedings, without conducting any other business, until Friday, January 5, 2024 at 11:00 a.m. Eastern Time to allow all parties time to process the court's ruling before the business to come before the 2023 annual meeting is conducted.

08:03 EST Strata Skin Sciences expands distribution agreement with Kosmo Meditech - STRATA Skin Sciences announced the expansion of a direct distribution agreement with Kosmo Meditech, which is now assigned to Kosmo's corporate parent, Cutech, Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea. The key highlights of this amendment, which reinforce STRATA's commitment to innovation and customer satisfaction, include: Extended term through December 31, 2026, ensuring a prolonged and stable partnership; Established defined annual and quarterly performance-based purchase requirements, including STRATA becoming sole provider of gas and consumables, securing a consistent demand for STRATA's products, providing a reliable forecast for production and inventory management, and ensuring stronger top-line revenue

07:16 EST Foresight Autonomous signs cooperation agreement with EV OEM in China - Foresight Autonomous Holdings announced the signing of a multi-phase cooperation agreement with a global electric vehicle original equipment manufacturer in China, specializing in EVs, rechargeable batteries and related products. As previously announced on September 21, 2023, the first phase of the agreement consists of a proof of concept project to evaluate Foresight's 3D perception capabilities, including high resolution point cloud, object detection and disparity map, for the possible enhancement of the OEM's current automotive vision solution. Upon successful completion of the POC project, the parties intend to negotiate a definitive commercial agreement for the joint development, integration and commercialization of Foresight's technology into the OEM's automotive vision systems. Furthermore, the OEM will introduce Foresight's technology to its subsidiaries, customers and partners, presenting Foresight as a business partner and thereby facilitating the relationship between Foresight and the OEM's partners.

07:05 EST American Lithium says INGEMMET, MINEM file petitions to Supreme Court of Peru - American Lithium has been notified that INGEMMET and MINEM have filed petitions to the Supreme Court of Peru to assume jurisdiction in the proceedings relating to the title of 32 disputed concessions out of a total of 174 owned by the Company's subsidiary, Macusani Yellowcake. If jurisdiction is established, INGEMMET and MINEM will attempt to persuade the Supreme Court to overturn the recent Superior Court ruling in favor of Macusani. Key facts: The Supreme Court normally only hears cases where the law is claimed to have been misapplied, where a mistrial has occurred or where a matter of national security is at stake; More than 75% of petitions to the Supreme Court are rejected before being heard because they do not meet the required threshold and the Supreme Court does not assume jurisdiction; In this case: All previous court hearings have been ruled in favor of the Company, including a very strong recent ruling from the Superior Court; The Superior Court unanimously rejected appeals filed by INGEMMET and MINEM in the first instance and refuted all of their arguments; The facts of this case are clear and the Company has never lost title to these "disputed" concessions. The Company believes there are no grounds for the Supreme Court to assume jurisdiction and these petitions should be rejected as soon as possible to mark the end of this case; The Company will take all other appropriate actions necessary to protect its interests; and This dispute relates to approx. 18% of the Company's total concessions on the Macusani Plateau and it will continue to aggressively develop its projects in any event.

07:01 EST VS Media receives non-compliance notification from Nasdaq - VS Media Holdings received written notification on December 27, 2023, from The Nasdaq Stock Market LLC that it no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to the Nasdaq Listing Rule 5550(a)(2). The closing bid price for the Company's ordinary shares had fallen below $1.00 per share for 33 consecutive business days and accordingly, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to the Nasdaq Listing Rule 5550(a)(2). However the Nasdaq Listing Rules also provide the Company a compliance period of 180 calendar days in which to regain compliance. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business days prior to June 24, 2024. If at any time during this 180 day period, the closing bid price of the Company's ordinary shares is at least $1.00 for a minimum of ten consecutive business days, the Company will be provided with written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance, it may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Nasdaq will inform that Company that it has been granted an additional 180 calendar days. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, its ordinary shares will be subject to delisting. The Company intends to actively monitor the bid price for its shares and is considering actions that it may take in response to this notification in order to regain compliance with the continued listing requirements, but no decisions about a response have been made at this time.

06:48 EST Bright Health amends credit facility - Bright Health Group entered into an amendment to its credit facility with J.P. Morgan that will reduce the final repayment amount by approximately $30M to approximately $298M Upon payment of such amount, which is expected to be made concurrently with the closing of the sale of the Company's California Medicare Advantage business, the Company's secured debt will be eliminated. The Company expects to use the remaining proceeds from the MA Sale to meaningfully improve the capital position of Bright Health's continuing business. The Company expects the MA Sale to close on or about January 1, 2024, and has received all required regulatory approvals. Upon closing of the MA Sale and the repayment of its secured debt, the Company expects to begin 2024 with approximately $90M of unregulated cash. In addition, the Company expects to have approximately $155M in excess cash surplus after reserving for expected medical costs and other anticipated wind-down expenses in its discontinued insurance business. Additionally, subject to adjustments and the conditions in the MA Sale agreement, the Company expects to receive an additional $110M from escrow. The Company intends to use such funds if and when received to offset liabilities in its discontinued ACA insurance business, such as the obligations under the CMS Repayment Agreements which come due on or before March 14, 2025. In 2024, Bright Health will solely focus on its continuing business, NeueHealth, increasing access to high-quality healthcare through its differentiated, value-driven care model that serves all populations across the ACA Marketplace, Medicare, and Medicaid.

06:34 EST Ault Alliance announces adjournment of annual meeting of stockholders - Ault Alliance announced the adjournment of the Company's 2023 Annual Meeting of Stockholders, which was scheduled to be held at 9:00 a.m. on December 29, 2023 but has been postponed due to the absence of quorum to conduct business. Based on the absence of quorum, the board of directors elected to adjourn the Meeting until 9:00 a.m. on January 12, 2024 for the purpose of allowing additional time for stockholders to vote on the Proposals contained in the Proxy Statement dated December 1, 2023.

06:22 EST MAS imposes civil penalty of S$3.9M on Credit Suisse - The Monetary Authority of Singapore, MAS, has imposed a civil penalty of S$3.9 million on Credit Suisse AG, for its failure to prevent or detect misconduct by its relationship managers, RMs, in the Singapore branch. The RMs had provided clients with inaccurate or incomplete post-trade disclosures, resulting in clients being charged spreads which were above bilaterally agreed rates for 39 over-the-counter, OTC, bond transactions. When Credit Suisse executes OTC transactions requested by its clients, it charges a spread over the price obtained from the relevant interbank counterparties. For the 39 transactions, the RMs had, in contravention of sections 201(c) and 201(d) of the Securities and Futures Act 2001: made false statements to their clients regarding the executed interbank prices and/or spreads charged; and/or omitted material information that the spreads charged were above the agreed rates. This enforcement action on Credit Suisse follows MAS' review of pricing and disclosure practices in the private banking industry. Investigations revealed that the bank had failed to put in place adequate controls, such as post-trade monitoring, to prevent or detect the RMs' misconduct. Credit Suisse has since strengthened its internal controls to prevent the recurrence of such misconduct. The bank has admitted liability under section 236C of the SFA for its failure to prevent or detect the misconduct by its RMs, and paid MAS the civil penalty. As part of the civil penalty settlement, Credit Suisse has also separately compensated its affected clients.

06:12 EST Autoliv retires repurchased shares, decreases number of issued shares - Autoliv announced that as of December 29, the total number of issued shares of common stock is 87,496,531 of which 82,642,524 shares are outstanding. Autoliv retired 1,511,933 shares of common stock that had been repurchased during the quarter which resulted in a decrease in the issued shares. The company now has a total of 87,496,531 issued shares of common stock of which 82,642,524 shares are outstanding. Each share of outstanding common stock is entitled to one vote. After the retirement of the repurchased shares, Autoliv holds 4,854,007 shares of common stock in treasury which have no voting rights or rights to participate in distributions under Delaware law.

06:08 EST Newmark arranges sale of Aon Center for $153.5M - Newmark announced it has arranged the sale of Aon Center, a 62-story trophy Class A office tower located in the heart of the Financial District in Downtown Los Angeles. The asset sold to Carolwood Equities for $153.5M. Newmark co-head. Newmark vice chairman David Milestone facilitated debt financing. The team was involved in two of the three biggest office sales that occurred in Los Angeles County this year.

06:04 EST Noah Holdings separates CEO, chairperson role and names Zhe Yin CEO - Noah Holdings announced that its board of directors has approved a separation of the chief executive officer and chairperson roles. Zhe Yin, co-founder and director of the company and chairman of Gopher Asset Management, has been appointed as the chief executive officer of the company, effective December 29 to succeed Jingbo Wang, who will remain as the chairwoman of the board and the chairwoman of the company's corporate governance and nominating committee. Yin is one of the founders of the company and has been a director since June 2007. He has been serving as the chairman of Gopher Asset Management, one of the company's consolidated affiliated entities, since March 2021, and served as the chief executive officer of Gopher Asset Management from April 2014 to March 2021 and as the chairman of Gopher Asset Management from February 2010 to April 2014.

05:07 EST RLX Technology extends $500M share repurchase program - RLX Technology announced that its board of directors has authorized the extension of its existing share repurchase program established in December 2021 for an additional 24-month period through December 31, 2025. Under the existing share repurchase program, the company may repurchase up to $500M of its ordinary shares represented by ADSs until December 31. As of December 28, the company had repurchased approximately $193.5M of its ordinary shares represented by ADSs.

04:36 EST Washington Trust announces repurchase program up to 850,000 shares - Washington Trust Bancorp said it has adopted a stock repurchase program, which authorizes the repurchase up to 850,000 shares of its common stock, or approximately 5% of its current outstanding shares. The 2024 repurchase program will commence on January 1, 2024 and expire on December 31, 2024.